LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Griffith University
Headquarters:
Brisbane, Nathan, Australia
Website:
http://www.griffith.edu.au
Year Founded:
1975
Status:
Non-biopharma
Biopharma related deals can be found by searching the organization's name in the
Deals
Module.
BioCentury
|
Mar 26, 2024
Distillery Therapeutics
Targeting interactions between host FHL1 and alphavirus NSP3
Read More
BioCentury
|
Jan 18, 2024
Distillery Therapeutics
Intranasal S. pyogenes vaccine
Read More
BioCentury
|
Oct 29, 2021
Discovery & Translation
Omics-based target identification in UK Biobank and COVID-19 cohorts
Plus: technologies from Harvard, Texas A&M, Disney lab and more
Read More
BioCentury
|
Oct 27, 2021
Distillery Therapeutics
Exosomes loaded with a ZFP362-DNMT3A fusion protein for HIV
Read More
BioCentury
|
Apr 29, 2020
Product Development
India emerging as major COVID-19 vaccine manufacturer
Serum Institute of India plans to make low-cost COVID-19 vaccines available to the developing world
Read More
BioCentury
|
Sep 27, 2018
Tools & Techniques
Antibacterial peptide derived from structure of a bacteria's essential protein
Read More
BioCentury
|
Dec 1, 2017
Company News
Astellas, MMV partner to identify antimalarial compounds
Read More
BioCentury
|
Sep 28, 2017
Translation in Brief
Coppering out
How pathogenic bacteria can escape copper toxicity
Read More
BioCentury
|
Sep 20, 2017
Distillery Therapeutics
Inflammation
Read More
BioCentury
|
May 15, 2014
Distillery Therapeutics
Indication: Infectious disease
Read More
Items per page:
10
1 - 10 of 18